Rise and fall of the Myth of the Good Pathogen in Evolutionary Biology and Medicine.

IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES
Fabio Zampieri, Fabio Michieletto, Alberto Zanatta
{"title":"Rise and fall of the Myth of the Good Pathogen in Evolutionary Biology and Medicine.","authors":"Fabio Zampieri, Fabio Michieletto, Alberto Zanatta","doi":"10.1016/j.ijid.2025.107836","DOIUrl":null,"url":null,"abstract":"<p><p>The history of the conceptions of evolution of virulence is well known. However, in this period following the Covid-19 pandemic, it may be useful to recap such a current topic. In the public debate, it has often been heard that the Covid-19 was destined to evolve into a less virulent form, because it would be in the virus's interest to coexist with the human population. This concept can be defined as the \"Myth of the good pathogen\" and originated from Smith's \"law of declining virulence\". The successes achieved thanks to vaccinations and antibiotics led the medical community, between the 1940s and 1970s, to argue that the battle against infectious diseases had been won. However, the AIDS pandemic brought back down to earth the scientific community in their speculations about plagues. Since 1970s, biologists have advanced the \"virulence transmission trade-offs theory\", a new model according to which intermediate virulence maximizes pathogenicity as a result of a trade-off between virulence and transmission. The introduction of trade-off models represented a crucial change that replaced the binary logic according to which natural selection shaped adaptations, while maladaptation escaped selection. This change was fundamental for the introduction of a new perspective in medicine, namely Evolutionary Medicine, which might be an essential tool not only for understanding the dynamics of epidemics, but also for preventing and curing infectious diseases.</p>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":" ","pages":"107836"},"PeriodicalIF":4.8000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijid.2025.107836","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

The history of the conceptions of evolution of virulence is well known. However, in this period following the Covid-19 pandemic, it may be useful to recap such a current topic. In the public debate, it has often been heard that the Covid-19 was destined to evolve into a less virulent form, because it would be in the virus's interest to coexist with the human population. This concept can be defined as the "Myth of the good pathogen" and originated from Smith's "law of declining virulence". The successes achieved thanks to vaccinations and antibiotics led the medical community, between the 1940s and 1970s, to argue that the battle against infectious diseases had been won. However, the AIDS pandemic brought back down to earth the scientific community in their speculations about plagues. Since 1970s, biologists have advanced the "virulence transmission trade-offs theory", a new model according to which intermediate virulence maximizes pathogenicity as a result of a trade-off between virulence and transmission. The introduction of trade-off models represented a crucial change that replaced the binary logic according to which natural selection shaped adaptations, while maladaptation escaped selection. This change was fundamental for the introduction of a new perspective in medicine, namely Evolutionary Medicine, which might be an essential tool not only for understanding the dynamics of epidemics, but also for preventing and curing infectious diseases.

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
18.90
自引率
2.40%
发文量
1020
审稿时长
30 days
期刊介绍: International Journal of Infectious Diseases (IJID) Publisher: International Society for Infectious Diseases Publication Frequency: Monthly Type: Peer-reviewed, Open Access Scope: Publishes original clinical and laboratory-based research. Reports clinical trials, reviews, and some case reports. Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases. Emphasizes diseases common in under-resourced countries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信